Belite Bio (BLTE) Total Current Liabilities (2021 - 2025)

Belite Bio's Total Current Liabilities history runs 5 years deep, the most recent figure standing at $9.9 million for Q4 2025.

• On a quarterly basis, Total Current Liabilities rose 63.34% year-over-year to $9.9 million in Q4 2025; TTM through Dec 2025 was $9.9 million, a 63.34% increase from a year earlier, with the FY2025 full-year figure at $9.9 million, up 63.34% from the prior year.
• Total Current Liabilities grew to $9.9 million in Q4 2025 per BLTE's latest filing, from $8.1 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $9.9 million in Q4 2025 and bottomed at $1.6 million in Q4 2021.
• The 5-year median for Total Current Liabilities is $4.8 million (2023), against an average of $5.2 million.
• Across the five-year window, Total Current Liabilities rose 28.69% in 2022 and jumped 72.67% in 2023, its largest moves.
• Year by year, Total Current Liabilities stood at $1.6 million in 2021, then advanced by 28.69% to $2.1 million in 2022, then soared by 72.67% to $3.6 million in 2023, then jumped by 66.53% to $6.0 million in 2024, then soared by 63.34% to $9.9 million in 2025.
• Per Business Quant, the three latest BLTE Total Current Liabilities figures stand at $9.9 million (Q4 2025), $8.1 million (Q3 2025), and $6.0 million (Q4 2024).